Remove Healthcare Remove Medicine Remove Side effects
article thumbnail

A New Era in Pharma DTC Marketing: Trust Over TV Spots

World of DTC Marketing

For decades, the image of pharmaceutical direct-to-consumer (DTC) marketing has been defined by glossy TV commercials: smiling patients, soft music, lengthy lists of side effects spoken at a rapid pace, and vague promises of a better life. Being honest about side effects—not burying them in fine print or fast talk.

article thumbnail

Ozempic: Weight Loss Miracle or Medical Mistake?

World of DTC Marketing

The weight loss side effect is real—but it’s just that: a side effect. Common side effects include nausea, vomiting, diarrhea, and fatigue. Medicine should not be about convenience or popularity. There’s another darker side to Ozempic’s popularity: shortages. More serious ones?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

EXPERT on Call – INCREASING ENGAGEMENT – Precision Medicine Meets Precision Marketing

PM360

An AltHarnessing genomics, AI, and digital innovation to shape the future of precision medicine. Innovation is rapidly shaping the healthcare landscape. 1 What Is Precision Medicine? An individualized approach may reduce the risks and inefficiencies of trial-and-error treatment selection and minimize potential side effects.

article thumbnail

AI model demonstrates potential for streamlining clinical trials

European Pharmaceutical Review

By choosing individuals who are most likely to benefit from treatment, the approach could help to reduce the cost of developing new medicines by streamlining clinical trials. New research has shown that AI can improve the precision of patient selection for clinical trials. Scientists tested their model on data for an Alzheimer’s drug.

article thumbnail

Nektar eyes pivotal trials for eczema drug cast off by Lilly

pharmaphorum

The company also pointed to a low rate of discontinuations and no increased risk of conjunctivitis, oral ulcers, or infections – all potential side effects with other biologics – in the study. R&D Deep Dive: Research and Development 2025 Every breakthrough in medicine, every new treatment that changes lives, starts with research.

article thumbnail

Lisata collaborates with GATC Health on drug development

Pharmaceutical Technology

By applying MAT analysis, any intellectual property generated will be derisked, offering predictions on efficacy, safety and side effects. Find out more Lisata will utilise GATC’s Multiomics Advanced Technology (MAT) platform that leverages AI to predict combination therapies that may include Lisata’s certepetide drug candidate.

article thumbnail

Potential blockbuster drugs to watch in 2025

European Pharmaceutical Review

Eleven medicines, covering key areas such as gene therapy, as well as drugs for obesity and oncology, are anticipated to attain blockbuster status or be therapeutic game-changers globally within five years to 2030, according to the 2025 edition of the Drugs to Watch report.